FDA.reportPublic FDA data

BUTYL ALCOHOL

Substance profile for UNII 8PJ61P6TS3, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for BUTYL ALCOHOL
Structure render from PubChem CID 263

Substance Identity#

UNII
8PJ61P6TS3
Preferred term
BUTYL ALCOHOL
Registry number
71-36-3
EC number
200-751-6
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C4H10O
Chemical structure for BUTYL ALCOHOL
Structure render from PubChem CID 263

Chemical And Database Identifiers#

InChIKey
LRHPLDYGYMQRHN-UHFFFAOYSA-N
SMILES
CCCCO
RxCUI
1310579
PubChem
263
NCIt
C76700
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound263https://pubchem.ncbi.nlm.nih.gov/compound/263
PubChem InChIKey SearchLRHPLDYGYMQRHN-UHFFFAOYSA-Nhttps://pubchem.ncbi.nlm.nih.gov/#query=LRHPLDYGYMQRHN-UHFFFAOYSA-N
RxNorm1310579https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1310579
NCI ThesaurusC76700https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C76700
FDA Substance Registration System8PJ61P6TS3https://precision.fda.gov/uniisearch/srs/unii/8PJ61P6TS3
European Community number200-751-6https://commonchemistry.cas.org/results?q=200-751-6

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3LANSOPRAZOLE7
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3075dbfb1-47c2-4578-a212-f8e656f0e9f92
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3PANTOPRAZOLE SODIUM2
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3GLIPIZIDE ER1
butyl alcoholINACTIVE INGREDIENT8PJ61P6TS3TEMAZEPAM1
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3Indomethacin Extended Release Capsules, USP Rx only2
Butyl AlcoholINACTIVE INGREDIENT8PJ61P6TS3ESOMEPRAZOLE MAGNESIUM1
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3Zonisamide1
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3GABAPENTIN2
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3DIVALPROEX SODIUM2
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3Indomethacin Capsules USP, 25 mg and 50 mg5
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3These highlights do not include all the information needed to use Calcium Acetate Capsules safely and effectively. See full prescribing information for Calcium Acetate Capsules. Calcium Acetate Capsules for ORAL use. Initial U.S. Approval: 19903
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3INDOMETHACIN1
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3Indomethacin Extended – Release Capsules, USP 75 mg5
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3These highlights do not include all the information needed to use omeprazole delayed-release capsules safely and effectively. See full prescribing information for omeprazole delayed-release capsules. OMEPRAZOLE Delayed-Release Capsules USP Initial U.S. Approval: 19895
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3These highlights do not include all the information needed to use OMEPRAZOLE delayed-release capsules, USP safely and effectively. See full prescribing information for OMEPRAZOLE delayed-release capsules, USP. OMEPRAZOLE Delayed-Release Capsules, USP, for oral use INITIAL U.S. APPROVAL: 19894
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3These highlights do not include all the information needed to use phentermine hydrochloride capsules, USP safely and effectively. See full prescribing information for phentermine hydrochloride capsules, USP. PHENTERMINE Hydrochloride Capsules, USP CIV Initial U.S. Approval: 19592
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3These highlights do not include all the information needed to use OMEPRAZOLE delayed-release capsules, USP safely and effectively. See full prescribing information for OMEPRAZOLE delayed-release capsules, USP. OMEPRAZOLE Delayed-Release Capsules, USP, for oral use INITIAL U.S. APPROVAL: 19892
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3Ursodiol Capsules, USP2
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3Tamsulosin hydrochloride capsules USP, 0.4 mg These highlights do not include all the information needed to use Tamsulosin hydrochloride safely and effectively. See full prescribing information for Tamsulosin hydrochloride. Tamsulosin hydrochloride (Tamsulosin hydrochloride) CAPSULE for ORAL use. Initial U.S. Approval: 19971
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3DOXYCYCLINE HYCLATE CAPSULES, USP2
butyl alcoholINACTIVE INGREDIENT8PJ61P6TS3These highlights do not include all the information needed to use omeprazole safely and effectively. See full prescribing information for omeprazole. OMEPRAZOLE delayed-release capsules USP, for oral use INITIAL U.S. APPROVAL: 19891
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3These highlights do not include all the information needed to use pantoprazole sodium delayed-release tablets USP safely and effectively. See full prescribing information for pantoprazole sodium delayed-release tablets USP. PANTOPRAZOLE Sodium delayed-release tablets USP for oral use Initial U.S. approval: 20001
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3These highlights do not include all the information needed to use OMEPRAZOLE delayed-release capsules, USP safely and effectively. See full prescribing information for OMEPRAZOLE delayed-release capsules, USP . OMEPRAZOLE Delayed-Release Capsules, USP , for oral use INITIAL U.S. APPROVAL: 198915
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3These highlights do not include all the information needed to use Divalproex Sodium Delayed Release Tablets safely and effectively. See full prescribing information for Divalproex Sodium Delayed Release Tablets. Divalproex Sodium Delayed Release Tablets USP for Oral use. Initial U.S. Approval: 19831
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3These highlights do not include all the information needed to use divalproex sodium delayed-release tablets, USP safely and effectively. See full prescribing information for divalproex sodium delayed-release tablets, USP. DIVALPROEX sodium delayed-release tablets, USP for oral use Initial U.S. Approval: 19831
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3These highlights do not include all the information needed to use omeprazole safely and effectively. See full prescribing information for omeprazole. OMEPRAZOLE DELAYED-RELEASE CAPSULES, USP INITIAL U.S. APPROVAL: 19892
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3These highlights do not include all the information needed to use pantoprazole sodium safely and effectively. See full prescribing information for pantoprazole sodium delayed-release tablets. Pantoprazole Sodium Delayed-Release Tablets, USP Initial U.S. approval: 20001
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3Isotretinoin Capsules USP1
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3Afeditab CR (Nifedipine Extended Release Tablets)4
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3Tamsulosin hydrochloride capsules USP, 0.4 mg These highlights do not include all the information needed to use Tamsulosin hydrochloride safely and effectively. See full prescribing information for Tamsulosin hydrochloride. Tamsulosin hydrochloride (Tamsulosin hydrochloride) CAPSULE for ORAL use. Initial U.S. Approval: 19971
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3Revised: January 2014 Glipizide Extended-Release Tablets For Oral Use Rx only2
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3These highlights do not include all the information needed to use duloxetine delayed-release capsules, USP safely and effectively. See full prescribing information for duloxetine delayed-release capsules, USP . DULOXETINE delayed-release capsules USP for oral use. Initial U.S. Approval: 20041
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3These highlights do not include all the information needed to use dicyclomine hydrochloride capsules, USP and dicyclomine hydrochloride tablets, USP safely and effectively. See full prescribing information for dicyclomine hydrochloride capsules, USP and dicyclomine hydrochloride tablets, USP. Dicyclomine hydrochloride capsules USP, for oral use Dicyclomine hydrochloride tablets USP, for oral use Initial U.S. Approval: 19501
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3These highlights do not include all the information needed to use omeprazole safely and effectively. See full prescribing information for omeprazole. OMEPRAZOLE DELAYED-RELEASE CAPSULES, USP Initial U.S. Approval: 19891
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3Lithium Carbonate Capsules USP Rx Only1
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3Glipizide Extended-Release Tablets Revised: January 2013 Rx only1
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3These highlights do not include all the information needed to use Omeprazole safely and effectively. See full prescribing information for Omeprazole. Omeprazole (Omeprazole) CAPSULE for ORAL use. Initial U.S. Approval: 20133
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3Gabapentin Capsules, USP 100 mg, 300 mg and 400 mg2
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3These highlights do not include all the information needed to use PANTOPRAZOLE SODIUM safely and effectively. See full prescribing information for PANTOPRAZOLE SODIUM. PANTOPRAZOLE SODIUM (PANTOPRAZOLE SODIUM) TABLET for ORAL use. Initial U.S. Approval: 20073
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3These highlights do not include all the information needed to use dicyclomine hydrochloride capsules, USP and dicyclomine hydrochloride tablets, USP safely and effectively. See full prescribing information for dicyclomine hydrochloride capsules, USP and dicyclomine hydrochloride tablets, USP. Dicyclomine hydrochloride capsules USP, for oral use Dicyclomine hydrochloride tablets USP, for oral use Initial U.S. Approval: 19501
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3DOXYCYCLINE HYCLATE CAPSULES, USP Rev. 11/11 Rx Only1
Butyl AlcoholINACTIVE INGREDIENT8PJ61P6TS3Drug Facts7
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3Drug Facts5
Butyl AlcoholINACTIVE INGREDIENT8PJ61P6TS3Drug Facts2
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3Drug Facts2
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3These highlights do not include all the information needed to use clopidogrel safely and effectively. See full prescribing information for clopidogrel tablets. Clopidogrel Tablets, USP Initial U.S. Approval: 19971
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3These highlights do not include all the information needed to use ziprasidone safely and effectively. See full prescribing information for ziprasidone. Ziprasidone Hydrochloride Capsules for Oral use Initial U.S. Approval: 20013
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS315f453ac-84b6-455e-9926-f51b8b9ac0dd1
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3These highlights do not include all the information needed to use omeprazole safely and effectively. See full prescribing information for omeprazole. OMEPRAZOLE DELAYED-RELEASE CAPSULES, USP INITIAL U.S. APPROVAL: 19892
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3MEXILETINE HYDROCHLORIDE CAPSULES USP 8739 8740 8741 Rx only2
Butyl AlcoholINACTIVE INGREDIENT8PJ61P6TS3CEPHALEXIN CAPSULES, USP1
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3These highlights do not include all the information needed to use dicyclomine hydrochloride capsules, USP and dicyclomine hydrochloride tablets, USP safely and effectively. See full prescribing information for dicyclomine hydrochloride capsules, USP and dicyclomine hydrochloride tablets, USP. Dicyclomine hydrochloride capsules USP, for oral use Dicyclomine hydrochloride tablets USP, for oral use Initial U.S. Approval: 19502
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3Myorisan TM (isotretinoin capsules, USP) 10 mg, 20 mg, 40 mg2
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3These highlights do not include all the information needed to use omeprazole safely and effectively. See full prescribing information for omeprazole. OMEPRAZOLE DELAYED-RELEASE CAPSULES, USP Initial U.S. Approval: 19891
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3Glipizide Extended-Release Tablets Rx only4
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3Temazepam Capsules, USP Novel Laboratories, Inc. Rx only4
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3Omeprazole Delayed-Release Capsules These highlights do not include all the information needed to use Omeprazole Delayed-Release Capsules safely and effectively. See full prescribing information for Omeprazole Delayed-Release Capsules. Initial U.S. Approval: 01/21/20091
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3Etodolac Capsules and Tablets, USP2
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3TussiCaps ® (Hydrocodone Polistirex and Chlorpheniramine Polistirex) Extended-Release Capsules CIII Rx only1
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3Ampicillin Capsules, USP1
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3These highlights do not include all the information needed to use phentermine hydrochloride capsules, USP safely and effectively. See full prescribing information for phentermine hydrochloride capsules, USP. PHENTERMINE Hydrochloride Capsules, USP CIV for oral use Initial U.S. Approval: 19592
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3Ethosuximide Capsules,USP1
butyl alcoholINACTIVE INGREDIENT8PJ61P6TS32ed81194-be24-45a0-8dde-fbc6ad3d7abe4
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3These highlights do not include all the information needed to use Fluoxetine safely and effectively. See full prescribing information for Fluoxetine. Fluoxetine capsules for oral use Initial U.S. Approval: 19871
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3Omeprazole Delayed-Release Capsules These highlights do not include all the information needed to use. See full prescribing information for. Initial U.S. Approval:1
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3Omeprazole Delayed-Release Capsules These highlights do not include all the information needed to use. See full prescribing information for. Initial U.S. Approval:1
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3FULL PRESCRIBING INFORMATION These highlights do not include all the information needed to use OMEPRAZOLE DELAYED-RELEASE safely and effectively. See full prescribing information for OMEPRAZOLE DELAYED-RELEASE. OMEPRAZOLE DELAYED-RELEASE (omeprazole) capsule, delayed release for oral use Initial U.S. Approval: 19893
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3These highlights do not include all the information needed to use REYATAZ safely and effectively. See full prescribing information for REYATAZ. REYATAZ ® (atazanavir sulfate) Capsules Initial U.S. Approval: 20032
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3Amoxicillin Capsules, Tablets and Powder for Oral Suspension, USP6
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3Dronabinol Capsules, USP CIII Rx only3
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3DANAZOL CAPSULES, USP Rx only2
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3RIFAMPIN CAPSULES, USP2
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3Indomethacin Capsules USP, 25 mg and 50 mg3
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS39c244c88-dcc4-44fb-b0d9-13732dc705f51
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3These highlights do not include all the information needed to use NEXIUM safely and effectively. See full prescribing information for NEXIUM. NEXIUM (esomeprazole magnesium) DELAYED-RELEASE CAPSULES NEXIUM (esomeprazole magnesium) FOR DELAYED-RELEASE ORAL SUSPENSION Initial U.S. Approval: 1989 (omeprazole)2
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3Lithium Carbonate Capsules USP Rx Only6
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3Omeprazole Delayed-Release Capsules These highlights do not include all the information needed to use See full prescribing information for use INITIAL U.S. APPROVAL: 20072
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3Rifampin Capsules, USP1
butyl alcoholINACTIVE INGREDIENT8PJ61P6TS3PHENTERMINE HYDROCHLORIDE CAPSULES, USP CIV1
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3Indomethacin Extended – Release Capsules, USP 75 mg1
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3Glipizide Extended-Release Tablets Rx only1
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3RIFAMPIN CAPSULES, USP2
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3Strazepam17
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3These highlights do not include all the information needed to use tamsulosin hydrochloride safely and effectively. See full prescribing information for tamsulosin hydrochloride. Tamsulosin Hydrochloride Capsules USP*, 0.4 mg Initial U.S. Approval: 19971
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3Indomethacin Capsules USP, 25 mg2
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3PROPAFENONE HYDROCHLORIDE EXTENDED RELEASE CAPSULES1
butyl alcoholINACTIVE INGREDIENT8PJ61P6TS3These highlights do not include all the information needed to use TEMODAR safely and effectively. See full prescribing information for TEMODAR. TEMODAR (temozolomide) Capsules TEMODAR (temozolomide) for Injection administered via intravenous infusion Initial U.S. Approval: 19991
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3Rifampin Capsules, USP1
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3Omeprazole 20 mg1
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3Lithium Carbonate Capsules USP Rx Only4
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3Lithium Carbonate Capsules USP Rx Only2
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3DOXEPIN HYDROCHLORIDE CAPSULES, USP2
butyl alcoholINACTIVE INGREDIENT8PJ61P6TS3Temazepam1
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3These highlights do not include all the information needed to use PRADAXA safely and effectively. See full prescribing information for PRADAXA. PRADAXA® (dabigatran etexilate mesylate) capsules for oral use Initial U.S. Approval: 20101
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3Dicyclomine Hydrochloride Tablets, USP Dicyclomine Hydrochloride Capsules, USP Rx Only1
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3PHENTERMINE HYDROCHLORIDE CAPSULES, USP CIV1
butyl alcoholINACTIVE INGREDIENT8PJ61P6TS3PHENTERMINE HYDROCHLORIDE CAPSULES, USP CIV1
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3Lithium Carbonate Capsules USP 150 mg, 300 mg and 600 mg2
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3These highlights do not include all the information needed to use NEXIUM safely and effectively. See full prescribing information for NEXIUM. NEXIUM (esomeprazole magnesium) DELAYED-RELEASE CAPSULES NEXIUM (esomeprazole magnesium) FOR DELAYED-RELEASE ORAL SUSPENSION Initial U.S. Approval: 1989 (omeprazole)1
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3PHENTERMINE HYDROCHLORIDE CAPSULES, USP CIV1
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3PHENTERMINE HYDROCHLORIDE CAPSULES, USP CIV1
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3Rifampin Capsules, USP1
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3These highlights do not include all the information needed to use Balsalazide Disodium Capsules, 750 mg safely and effectively. See full prescribing information for Balsalazide Disodium Capsules. Balsalazide Disodium Capsules for oral use Initial U.S. Approval: 20001
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS34b5513c3-b57f-46f1-9855-dad1063aa4c92
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3LITHIUM CARBONATE CAPSULES, USP Rev. 12/02 Rx Only1
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3ELMIRON ® -100 mg (pentosan polysulfate sodium) Capsules2
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3Lithium Carbonate Capsules USP 150 mg, 300 mg and 600 mg2
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3e1171b54-c1a3-4220-bc8a-92f49f2701832
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3DIVALPROEX SODIUM DELAYED-RELEASE TABLETS USP 7439 7440 7441 Rx only4
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3These highlights do not include all the information needed to use omeprazole delayed-release capsules safely and effectively. See full prescribing information for omeprazole delayed-release capsules . OMEPRAZOLE DELAYED-RELEASE CAPSULES INITIAL U.S. APPROVAL: 19892
n-Butyl AlcoholINACTIVE INGREDIENT8PJ61P6TS3Diltiazem Hydrochloride Extended Release Tablets Issued: October 2005 Rx Only Once-a-day dosage1
n-butyl alcoholINACTIVE INGREDIENT8PJ61P6TS3Diclofenac Sodium Delayed-Release Tablets USP 25 mg, 50 mg, 75 mg1
butyl alcoholINACTIVE INGREDIENT8PJ61P6TS3TEMAZEPAM CAPSULE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3945
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3INDOMETHACIN CAPSULE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3911
butyl alcoholINACTIVE INGREDIENT8PJ61P6TS3CELLCEPT (MYCOPHENOLATE MOFETIL) TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3807
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3MEXILETINE HYDROCHLORIDE CAPSULE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3749
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3OMEPRAZOLE CAPSULE, DELAYED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3741
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3ETODOLAC CAPSULE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALTIY CARE PRODUCTS LLC]3619
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3NEXIUM (ESOMEPRAZOLE MAGNESIUM) CAPSULE, DELAYED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3473